Financhill
Back

Journey Medical Quote, Financials, Valuation and Earnings

Journey Medical Price Quote

$5.30
-0.07 (1.92%)
(Updated: November 23, 2024 at 5:32 AM ET)

Journey Medical Key Stats

Sell
49
Journey Medical (DERM) is a Sell

Day range:
$5.11 - $5.65
52-week range:
$2.85 - $8.11
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.85
P/B ratio:
10.27%

Volume:
119.6K
Avg. volume:
133.1K
1-year change:
25.47%
Market cap:
$112.2M
Revenue:
$79.2M
EPS:
$-0.94

How Much Does Journey Medical Make?

Is Journey Medical Growing As A Company?

  • What Is Journey Medical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.58%
  • What Is Journey Medical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Journey Medical Stock Price Performance

  • Did Journey Medical Stock Go Up Last Month?
    Journey Medical share price went down by -12.68% last month
  • Did DERM's Share Price Rise Over The Last Year?
    DERM share price rose by 25.47% over the past 1 year

What Is Journey Medical 52-Week High & Low?

Journey Medical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Journey Medical?

  • How Much Debt Does Journey Medical Have?
    Total long term debt quarterly is $19.8M
  • How Much Cash Does Journey Medical Have?
    Cash and short term investments quarterly total is $22.5M
  • What Is Journey Medical’s Book Value Per Share?
    Book value per share is 0.53

Is Journey Medical Cash Flow Positive?

  • What Is DERM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$27.9M
  • What Is Journey Medical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $25.6M
  • What Is Journey Medical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Journey Medical Return On Invested Capital

  • Is Management Doing A Good Job?
    DERM return on invested capital is -64.68%
  • What Is Journey Medical Return On Assets?
    ROA measures how assets are converting to revenues and is -27.08%
  • What Is DERM Return On Equity?
    ROE is a measure of profitability and is -125.77%

Journey Medical Earnings Date & Stock Price

Journey Medical Competitors

  • Who Are Journey Medical's Competitors?
    Below is a list of companies who compete with Journey Medical or are related in some way:
    • Elutia Inc (ELUT)
    • Eton Pharmaceuticals Inc (ETON)
    • Fortress Biotech Inc (FBIO)
    • Heron Therapeutics Inc (HRTX)
    • NovaBay Pharmaceuticals Inc (NBY)

Journey Medical Dividend Yield

Journey Medical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -57.65% 1.68%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 10.00
Upside from Last Price: 86.22%

Major Shareholders

  • How many DERM shares are owned by institutional investors?
    2.5M DERM shares are owned by institutional investors
  • How many DERM shares are owned by insiders?
    3.1M DERM shares are owned by insiders